JP5401540B2 - 硝酸酸化物供与プロスタミド類 - Google Patents

硝酸酸化物供与プロスタミド類 Download PDF

Info

Publication number
JP5401540B2
JP5401540B2 JP2011508009A JP2011508009A JP5401540B2 JP 5401540 B2 JP5401540 B2 JP 5401540B2 JP 2011508009 A JP2011508009 A JP 2011508009A JP 2011508009 A JP2011508009 A JP 2011508009A JP 5401540 B2 JP5401540 B2 JP 5401540B2
Authority
JP
Japan
Prior art keywords
ono
independently
alkyl
alkenyl
alkynyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011508009A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519910A5 (enExample
JP2011519910A (ja
Inventor
ベネディニ，フランチェスカ
ビオンディ，ステファノ
チロリ，ヴァレリオ
チョン，ウエスリー，クワン，ムン
ドン，リミン
クラウス，アチム，ハンス−ピター
ニコリ，ファビオ
プラサンナ，ガネシュ
ヴァーニア，ウイリアム，フランソワ
ヤン，イー
Original Assignee
ニコックス エス エイ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニコックス エス エイ filed Critical ニコックス エス エイ
Publication of JP2011519910A publication Critical patent/JP2011519910A/ja
Publication of JP2011519910A5 publication Critical patent/JP2011519910A5/ja
Application granted granted Critical
Publication of JP5401540B2 publication Critical patent/JP5401540B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2011508009A 2008-05-09 2009-05-11 硝酸酸化物供与プロスタミド類 Active JP5401540B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US61/052,084 2008-05-09
US13933308P 2008-12-19 2008-12-19
US61/139,333 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (3)

Publication Number Publication Date
JP2011519910A JP2011519910A (ja) 2011-07-14
JP2011519910A5 JP2011519910A5 (enExample) 2012-03-15
JP5401540B2 true JP5401540B2 (ja) 2014-01-29

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011508009A Active JP5401540B2 (ja) 2008-05-09 2009-05-11 硝酸酸化物供与プロスタミド類

Country Status (8)

Country Link
US (1) US8101658B2 (enExample)
EP (1) EP2274279B1 (enExample)
JP (1) JP5401540B2 (enExample)
CN (1) CN102099330B (enExample)
AR (1) AR076731A1 (enExample)
CA (1) CA2723704C (enExample)
ES (1) ES2428387T3 (enExample)
WO (1) WO2009136281A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8519178B2 (en) 2009-06-22 2013-08-27 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
BR112013020719B1 (pt) * 2011-02-14 2018-04-17 Allergan, Inc. Composições de derivados de bimatoprost tipo éster e métodos
EP3421042B1 (en) 2012-03-07 2024-04-17 Beyond Air Ltd Inhalation of nitric oxide for treating respiratory diseases
US9045443B2 (en) 2012-05-31 2015-06-02 Theravance Biopharma R&D Ip, Llc Nitric oxide donor neprilysin inhibitors
WO2016155906A1 (en) 2015-03-31 2016-10-06 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
WO2017042636A1 (en) 2015-09-09 2017-03-16 Advanced Inhalation Therapies (Ait) Ltd. Nitric oxide inhalation therapy for infants with bronchiolitis
CA3043000A1 (en) 2016-11-08 2018-05-17 Bausch & Lomb Incorporated Nitric oxide releasing prostaglandin derivatives for treating normal tension glaucoma
ES2836118T3 (es) 2018-02-21 2021-06-24 Nicox Sa Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
RU2718744C2 (ru) * 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
SMT202100034T1 (it) 2018-07-12 2021-03-15 Nicox Sa Composizioni oftalmiche contenenti una prostamide che rilascia ossido nitrico
ES2964005T3 (es) * 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico
US20240158345A1 (en) * 2021-02-03 2024-05-16 Nicox S.A. Process for the preparation of a nitric oxide donating prostaglandin analogue
JP2024533601A (ja) 2021-09-20 2024-09-12 ニコックス エス．エー． 神経保護剤としての一酸化窒素放出プロスタミド
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
HRP20241504T1 (hr) 2022-07-07 2025-01-03 Nicox S.A. Industrijski postupak priprave (1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(etilamino)-7-okso-2-hepten-1-il]3,5-dihidroksiciklopentil]-1-(2-feniletil)-2-propen-1-ilnog estera 6(nitroksi)heksanske kiseline i produkta visoke čistoće
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药（常熟）有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
SI1480949T1 (sl) * 2002-03-01 2015-09-30 Allergan, Inc. Priprava prostamidov
ES2767136T3 (es) * 2004-01-05 2020-06-16 Nicox Sa Derivados de prostaglandinas
EP1899295A2 (en) * 2005-06-29 2008-03-19 Pfizer, Inc. Prostaglandin derivatives
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
AR076731A1 (es) 2011-07-06
CA2723704C (en) 2017-08-22
US8101658B2 (en) 2012-01-24
EP2274279B1 (en) 2013-07-31
CA2723704A1 (en) 2009-11-12
WO2009136281A1 (en) 2009-11-12
CN102099330A (zh) 2011-06-15
EP2274279A1 (en) 2011-01-19
ES2428387T3 (es) 2013-11-07
CN102099330B (zh) 2014-04-30
HK1160835A1 (en) 2012-08-17
US20110092590A1 (en) 2011-04-21
JP2011519910A (ja) 2011-07-14

Similar Documents

Publication Publication Date Title
JP2011519910A (ja) 硝酸酸化物供与プロスタミド類
JP7163379B2 (ja) Ｉｌ－１７調節剤としてのスピロ環インドリン
EP1697308B1 (en) Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease
US20230271973A1 (en) Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
CA3110767A1 (en) Benzimidazolone derivatives, and analogues thereof, as il-17 modulators
CA3103711A1 (en) Spirocyclic indane analogues as il-17 modulators
CA3119002A1 (en) Functionalised amine derivatives as il-17 modulators
PT96234A (pt) Agentes inibidores da protease de hiv uteis no tratamento da sida
BR112015019634B1 (pt) Derivados de pirrolo[2,3-d]pirimidina como inibidores de janus kinase (jak), seu uso e composição farmacêutica ou veterinária que os compreende
CA3244866A1 (en) DI-CYCLOPROPYL-BASED IL-17A MODULATORS AND THEIR USES
WO2021204800A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
KR20190016516A (ko) 페닐 프로판아미드 유도체와 이를 제조하는 방법, 및 이를 약학적으로 사용하는 방법
JP2025507852A (ja) 中環状または大環状ベンジル置換複素環誘導体および関連の使用
IL269836A (en) N-Arylethyl-2-aminoquinoline-4-carboxamides Converted and their use
JP2024510778A (ja) １，３－置換シクロブチル誘導体及びその使用
AU2020394597A1 (en) 1,2,4-oxadiazole derivatives as liver X receptor agonists
JP2009500315A (ja) フルオロプロスタグランジンのニトロ誘導体
WO2017144015A1 (zh) 一种新毒素及其中间体的制备方法
HK1160835B (en) Nitric oxide donating prostamides
EP0432975A1 (en) Cyclic renin inhibitors
EP1912963B1 (en) Cyclic ketal beta-secretase inhibitors for the treatment of alzheimer's disease
AU2004253667A1 (en) Macrocyclic compounds having aspartic protease inhibiting activity and pharmaceutical uses thereof
HK1243063A1 (en) Pyrrolo [2, 3-d] pyrimidine derivatives as inhibitors of janus-related kinases (jak)
HK1213881B (en) Pyrrolo [2, 3-d] pyrimidine derivatives as inhibitors of janus-related kinases (jak)
HK1168837B (en) Tetracycline compounds

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120124

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130919

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20131001

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20131028

R150 Certificate of patent or registration of utility model

Ref document number: 5401540

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250